Literature DB >> 15114058

Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients.

Roland Jacobs1, Klaus Weber, Katy Wendt, Hans Heiken, Reinhold E Schmidt.   

Abstract

HIV patients either on highly active antiviral therapy (HAART) or therapy naive were analyzed for their CD56 phenotype and cytokine production in comparison to healthy controls (HC). Both NK cell populations (CD56(dim) and CD56(bright)) are found to be present in all groups with selectively decreased CD56(dim) NK cells in HAART naive patients. Patients on HAART exhibited significantly diminished numbers of CD161+CD56(dim) NK cells. CD56(dim) were equally potent in producing IFNgamma in all three groups. The number of TNFalpha+CD56(bright) NK cells from patients on HAART and TNFalpha+CD56(dim) NK cells from HAART naive patients was significantly reduced as compared to healthy controls. In summary our data revealed that functional capacities and coexpression patterns of lectin-like receptors on lymphocytes are differentially affected in HIV patients depending on the state of therapy (under HAART or HAART naive) or the cell type (NK or T cells), respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114058     DOI: 10.1023/B:JOCI.0000025449.16468.6f

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.

Authors:  Francisco Borrego; Juraj Kabat; Tolib B Sanni; John E Coligan
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

2.  CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.

Authors:  W E Carson; T A Fehniger; M A Caligiuri
Journal:  Eur J Immunol       Date:  1997-02       Impact factor: 5.532

3.  CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.

Authors:  R Jacobs; G Hintzen; A Kemper; K Beul; S Kempf; G Behrens; K W Sykora; R E Schmidt
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

4.  Immunologic and virologic studies in long-term nonprogressors with HIV-1 infection.

Authors:  M Mendila; H Heiken; S Becker; M Stoll; A Kemper; R Jacobs; R E Schmidt
Journal:  Eur J Med Res       Date:  1999-10-15       Impact factor: 2.175

5.  Activation of signal transduction and apoptosis in healthy lymphomonocytes exposed to bystander HIV-1-infected cells.

Authors:  I Abbate; F Dianzani; M R Capobianchi
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

6.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  Adrenaline-induced immunological changes are altered in patients with rheumatoid arthritis.

Authors:  J M Kittner; R Jacobs; C R Pawlak; C J Heijnen; M Schedlowski; R E Schmidt
Journal:  Rheumatology (Oxford)       Date:  2002-09       Impact factor: 7.580

8.  CD16- CD56+ natural killer cells after bone marrow transplantation.

Authors:  R Jacobs; M Stoll; G Stratmann; R Leo; H Link; R E Schmidt
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

9.  Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.

Authors:  A Oliva; A L Kinter; M Vaccarezza; A Rubbert; A Catanzaro; S Moir; J Monaco; L Ehler; S Mizell; R Jackson; Y Li; J W Romano; A S Fauci
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.

Authors:  K Ljunggren; A Karlson; E M Fenyö; M Jondal
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

View more
  4 in total

1.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

2.  Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection.

Authors:  Lucy Golden-Mason; Nicole Castelblanco; Cliona O'Farrelly; Hugo R Rosen
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

3.  Interleukin-21 differentially affects human natural killer cell subsets.

Authors:  Katy Wendt; Esther Wilk; Sabine Buyny; Reinhold Ernst Schmidt; Roland Jacobs
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

4.  CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.

Authors:  Ayako Kurioka; Cormac Cosgrove; Yannick Simoni; Bonnie van Wilgenburg; Alessandra Geremia; Sophia Björkander; Eva Sverremark-Ekström; Christine Thurnheer; Huldrych F Günthard; Nina Khanna; Lucy Jane Walker; Carolina V Arancibia-Cárcamo; Evan W Newell; Christian B Willberg; Paul Klenerman
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.